跳至主要内容
临床试验/NL-OMON51074
NL-OMON51074招募中3 期

Drug-COated Balloon Coronary Angioplasty versus Stenting for Treatment of Disease Adjacent to a Chronic Total Occlusion - The Co-CTO Trial. - The Co-CTO trial

Vrije Universiteit Medisch Centrum0 个研究点目标入组 144 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age >= 18 years
  • Clinical indication for revascularization of the CTO as determined by the
  • local heart team (based on symptoms, documented ischemia, and viability)
  • Successful recanalization of the CTO with residual disease adjacent to the
  • initial lesion

排除标准

  • Dissection affecting the flow (TIMI score <3), significant recoil (>30%) or
  • coronary perforation after predilation
  • Reference diameter of the vessel is <2.5 mm or >4.0 mm
  • Bifurcation lesion requiring the stenting of the side branch
  • Left main lesion
  • Acute coronary syndrome
  • Cardiogenic shock
  • Severe kidney disease defined as an eGFR < 30 ml/min
  • Pregnancy
  • Life expectancy < 12 months
  • Inability to give written consent

研究者

相似试验

Drug-COated Balloon Coronary Angioplasty versus... | 临床试验